Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05953532 · ClinicalTrials.gov registry record · NA
Developing a mHealth Simulation Platform for Youth
A NA study, sponsored by Ohio State University.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT05953532 is a NA study that has completed, run by Ohio State University. The registered enrollment target is 20 participants.
The verdict
NCT05953532, a NA study, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The investigators will conduct a 12-week single group feasibility pilot field study among youth who will use a diabetes technology education application in their natural home environment.
Interventions
- OTHER A1Control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2023-11-01 |
| Est. Completion | 2025-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05953532
The ClinicalTrials.gov registry entry for NCT05953532 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which A1Control is the first listed.
NCT05953532 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05953532 about?
NCT05953532 is a clinical study titled "Developing a mHealth Simulation Platform for Youth". The investigators will conduct a 12-week single group feasibility pilot field study among youth who will use a diabetes technology education application in their natural home environment.
What is the current status of trial NCT05953532?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2023-11-01. Estimated completion is 2025-07-31.
What interventions are being tested in trial NCT05953532?
The interventions under investigation include: A1Control (OTHER).
Who is sponsoring clinical trial NCT05953532?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.